Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vascular endothelial growth factor platelet counts, and prognosis in renal cancer.

Literature DB >> 10232320

Vascular endothelial growth factor platelet counts, and prognosis in renal cancer.

K J O'Byrne, N Dobbs, D Propper, K Smith, A L Harris.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 1999 PMID： 10232320 DOI： 10.1016/S0140-6736(99)00471-7

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Stability analysis of vascular endothelial growth factor in cerebrospinal fluid.

Authors: Jun Yang; Stephen M Dombrowski; Abhishek Deshpande; Natalie Krajcir; Serge El-Khoury; Chandra Krishnan; Mark G Luciano
Journal: Neurochem Res Date: 2011-06-04 Impact factor: 3.996

2. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.

Authors: Yuri Shimanuki; Kazuhisa Takahashi; Ri Cui; Satoshi Hori; Fumiyuki Takahashi; Hideaki Miyamoto; Yoshinosuke Fukurchi
Journal: Lung Date: 2005 Jan-Feb Impact factor: 2.584

3. Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice.

Authors: H Kanayama; S Yano; S J Kim; S Ozawa; L M Ellis; I J Fidler
Journal: Clin Exp Metastasis Date: 1999 Impact factor: 5.150

4. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.

Authors: A M Jubb; T Q Pham; A M Hanby; G D Frantz; F V Peale; T D Wu; H W Koeppen; K J Hillan
Journal: J Clin Pathol Date: 2004-05 Impact factor: 3.411

Review 5. A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful?

Authors: E Hormbrey; P Gillespie; K Turner; C Han; A Roberts; D McGrouther; A L Harris
Journal: Clin Exp Metastasis Date: 2002 Impact factor: 5.150

6. Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

Authors: Darren R Feldman; Michael S Baum; Michelle S Ginsberg; Hani Hassoun; Carlos D Flombaum; Susanne Velasco; Patricia Fischer; Ellen Ronnen; Nicole Ishill; Sujata Patil; Robert J Motzer
Journal: J Clin Oncol Date: 2009-02-17 Impact factor: 44.544

7. Circulating Vascular Endothelial Growth Factor and Soluble fms-Like Tyrosine Kinase-1 as Biomarkers for Endometrial Remodeling Across the Menstrual Cycle.

Authors: Jessica R Zolton; Lindsey A Sjaarda; Sunni L Mumford; Elizabeth A DeVilbiss; Keewan Kim; Kerry S Flannagan; Jeannie G Radoc; Neil J Perkins; Robert M Silver; Jean Wactawski-Wende; Micah J Hill; Alan H DeCherney; Enrique F Schisterman
Journal: Obstet Gynecol Date: 2021-01-01 Impact factor: 7.623